Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Hope & Destiny: The Patient and Parent’s Guide to Sickle Cell Disease and Sickle Cell Trait
Sickle Cell Disease is the most common blood disorder in the U.S. Hope & Destiny provides clear-cut and in-depth information for the more than 80,000 Americans living with sickle cell disease. Written especially for parents and caregivers, it offers the latest information on preventing complications, research, and treatment. The knowledge patients and family members need is organized in an easy-to-read format that promotes overall healthy living.
+myBinderRelated Content
-
FDA Approves Hydroxyurea Tablets for Pediatric Patients With Sickle Cell AnemiaThe US Food and Drug Administration (FDA...
-
MARAC Statement: Crizanlizumab (Adakveo)July 7, 2023 - SCDAA’s Medical and Res...
-
Early occurrence of red blood cell alloimmunization in patients with sickle cell diseaseRed blood cell (RBC) alloimmunization is...
-
Piracetam for reducing the incidence of painful sickle cell disease crisesBACKGROUND: Sickle cell disease is one ...
-
University of Pittsburgh School of MedicineThe University of Pittsburgh School of M...
-
MARAC Advisory Statement: Update About COVID-19December 23, 2021 – The Sickle Cell Di...
-
FDA Clears Graphite Bio to Begin Trial for Gene Therapy in Sickle Cell DiseaseIn response to Graphite Bio’s investig...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
